Burstein HJ, Curigliano G, Thürlimann B, Weber WP, Poortmans P, Regan MM, et al. Customizing local and systemic therapies for women with early breast cancer: The St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol. 2021;32:1216–35. https://doi.org/10.1016/j.annonc.2021.06.023.

Article  CAS  PubMed  Google Scholar 

Meattini I, Becherini C, Boersma L, Kaidar-Person O, Marta GN, Montero A, et al. European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. Lancet Oncol. 2022;23:e21-31. https://doi.org/10.1016/S1470-2045(21)00539-8.

Article  PubMed  Google Scholar 

Brunt AM, Haviland JS, Sydenham M, Agrawal RK, Algurafi H, Alhasso A, et al. Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer. J Clin Oncol. 2020;38:3261–72. https://doi.org/10.1200/JCO.19.02750.

Article  PubMed  PubMed Central  Google Scholar 

Murray Brunt A, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395:1613–26. https://doi.org/10.1016/S0140-6736(20)30932-6.

Article  PubMed  PubMed Central  Google Scholar 

Lewis P, Brunt AM, Coles C, Griffin S, Locke I, Roques T, et al. Moving forward fast with FAST-Forward. Clin Oncol (R Coll Radiol). 2021;33:427–9. https://doi.org/10.1016/j.clon.2021.04.007.

Article  CAS  PubMed  Google Scholar 

Loibl S, Andre F, Bachelot T, Barrios CH, Bergh J, Burstein HJ, et al. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024;35:159–82. https://doi.org/10.1016/j.annonc.2023.11.016.

Article  CAS  PubMed  Google Scholar 

Yoshimura M, Yamauchi C, Sanuki N, Hamamoto Y, Hirata K, Kawamori J, et al. The Japanese Breast Cancer Society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition. Breast Cancer. 2024;31:347–57. https://doi.org/10.1007/s12282-024-01568-4.

Article  PubMed  Google Scholar 

The Japanese Breast Cancer Society. Clinical practice guidelines of breast cancer, 2022 edition. https://jbcs.xsrv.jp/guideline/2022/ Accessed 17 July 2024.

Purdie TG, Dinniwell RE, Letourneau D, Hill C, Sharpe MB. Automated planning of tangential breast intensity-modulated radiotherapy using heuristic optimization. Int J Radiat Oncol Biol Phys. 2011;81:575–83. https://doi.org/10.1016/j.ijrobp.2010.11.016.

Article  PubMed  Google Scholar 

Brunt AM, Wheatley D, Yarnold J, Somaiah N, Kelly S, Harnett A, et al. Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial. Radiother Oncol. 2016;120:114–8. https://doi.org/10.1016/j.radonc.2016.02.027.

Article  PubMed  PubMed Central  Google Scholar 

Machiels M, Weytjens R, Bauwens W, Vingerhoed W, Billiet C, Huget P, et al. Accelerated adaptation of ultrahypofractionated radiation therapy for breast cancer at the time of the COVID-19 pandemic. Clin Oncol (R Coll Radiol). 2021;33:e166–71. https://doi.org/10.1016/j.clon.2020.11.027.

Article  CAS  PubMed  Google Scholar 

Rivera S, Brion T, Kirova Y, Racadot S, Benchalal M, Clavier JB, et al. Acute toxicity associated with a 3-week versus a standard 5-week regimen for locoregional breast radiotherapy delivered in the UNICANCER HypoG-01 phase III trial. Ann Oncol. 2021;32:2.

Article  Google Scholar 

Chakraborty S, Chatterjee S, Hyport Adjuvant Author Group. HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis. Radiother Oncol. 2022;174:59–68. https://doi.org/10.1016/j.radonc.2022.07.003.

Article  CAS  PubMed  Google Scholar 

Okonogi N, Kono S, Karasawa K, Banu PA, Xu X, Erawati D, et al. Significance of hypofractionated radiotherapy in postoperative irradiation for breast cancer: an Asian multi-institutional prospective study. Clin Oncol (R Coll Radiol). 2023;35:463–71. https://doi.org/10.1016/j.clon.2023.04.007.

Article  CAS  PubMed  Google Scholar 

Xie Y, Wang Q, Hu T, Chen R, Wang J, Chang H, et al. Risk factors related to acute radiation dermatitis in breast cancer patients after radiotherapy: a systematic review and meta-analysis. Front Oncol. 2021;11: 738851. https://doi.org/10.3389/fonc.2021.738851.

Article  PubMed  PubMed Central  Google Scholar 

Bandera EV, Maskarinec G, Romieu I, John EM. Racial and ethnic disparities in the impact of obesity on breast cancer risk and survival: a global perspective. Adv Nutr. 2015;6:803–19. https://doi.org/10.3945/an.115.009647.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Winchester DP, Cox JD. Standards for breast-conservation treatment. CA Cancer J Clin. 1992;42:134–62. https://doi.org/10.3322/canjclin.42.3.134.

Article  CAS  PubMed  Google Scholar